Session
Chair(s)
EUROGIN 2022 - Sessions On-Demand (SOD)
List of sessions included in the SOD offer
MSS 01-A - HPV diseases and SARS-CoV2 •
Part A: COVID-19 and HPV vaccination
Chairs: S. Franceschi - S. Hanley
MSS 01-B - HPV diseases and SARS-CoV2 •
Part B: COVID-19 and cervical cancer screening
Chairs: F. Carozzi - E. Franco
MSS 02 - HPV vaccines - Special session
Chairs: A. Giuliano
MSS 03 - New evidence on the effectiveness of HPV vaccination against invasive cervical cancer: a global view
Chairs: S. Sudenga - P. Sasieni
MSS 04 - Routine HPV screening: how to modulate and manage HPV screening by age
Chairs: P. Giorgi Rossi - G. Ogilvie
MSS 05 - HPV vaccination strategies, impact and safety by age, current knowledge
Chairs: J. Dillner - A. Giuliano
MSS 06 - Assessing risk of cervical cancer in the post vaccination era
Chairs: J. Dillner - M. Lehtinen
MSS 07-A - HPV screening: first experiences •
Part A: HPV screening in the real life, the first experiences
Chairs: J. Bonde - S. Van Dijk
MSS 07-B - HPV screening: first experiences •
Part B: HPV self-sampling - Real life implementation experiences
Chairs: J. Bonde - S. Van Dijk
Session
Chair(s)
SS 04 - HPV and anal diseases screening
Chair: A. Nyitray - L. Abramowitz
SS 12 - The role of HPV circulating DNA for the surveillance of cancer recurrence in HPV-associated cancer
Chair: H. Mirghani
Session
Chair(s)
WS 01-A - The feasibility of personalized screening in organized programs •
Part A: Reaching the unreached population
Chairs: S. Van Dijk - P. Giorgi Rossi - M. Elfström
WS 01-B - The feasibility of personalized screening in organized programs •
Part B: Managing the screened population
Chairs: S. Van Dijk - P. Giorgi Rossi - M. Elfström
WS 02 - HPV infection and anal diseases •
Prevention of anal cancer post-ANCHOR workshop
Chair: J. Palefsky
Session
Chair(s)
HN 01 - Screening, prevention and epidemiology
Chair: K. A. Lang Kuhs - T. Waterboer
HN 02 - Survivorship and surveillance
Chair: E. Rettig
HN 03 - Management / Clinical trials
Chair: J. P. Klussmann
HN 04 - Submitted papers
Chair: T. Dalianis
HN 05 - Carcinogenesis & molecular characterization
Chair: S. Virani
HN 06 - Immunologic considerations
Chair: S. Van der Burg
Price: €180
The SOD service will remain available until August 12, 2022.
Not yet registered to the conference?
Selected session of the EUROGIN 2022 congress has been recorded and made available for digital access after the congress to delegates having booked this service with their registration.
The SOD access cannot be booked separately but only as an additional option by participants being already registered for the conference.
The SOD digital access includes:
- Listening to the speakers' talks
- Viewing of presentation slides
Speakers are shown in form of a fixed portrait picture. Please note that there will be no video of the speaker or the conference room.
EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.
EUROVIR, owning the trademark EUROGIN, is a Trusted Partner of Ethical MedTech.